Synergistic effects of vancomycin and β-lactams against vancomycin highly resistant Staphylococcus aureus

New Approaches to Drug Discovery for Combating MRSA

(2016) Hiroshi Tomoda   CHEMICAL & PHARMACEUTICAL BULLETIN

Unexpectedly long half-life of metformin elimination in cases of metformin accumulation

(2015) F. Kajbaf et al.   DIABETIC MEDICINE

Phenotypic and genomic comparisons of highly vancomycin-resistant Staphylococcus aureus strains developed from multiple clinical MRSA strains by in vitro mutagenesis

(2015) Kenichi Ishii et al.   Scientific Reports

Lysocin E is a new antibiotic that targets menaquinone in the bacterial membrane

(2014) Hiroshi Hamamoto et al.   Nature Chemical Biology

Efficacy and Safety of Vildagliptin as Add-on to Metformin in Japanese Patients with Type 2 Diabetes Mellitus

(2014) Masato Odawara et al.   Diabetes Therapy

Novel Combinations of Vancomycin plus Ceftaroline or Oxacillin against Methicillin-Resistant Vancomycin-Intermediate Staphylococcus aureus (VISA) and Heterogeneous VISA

(2013) B. J. Werth et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

First case of infection with vancomycin-resistant Staphylococcus aureus in Europe

(2013) José Melo-Cristino et al.   LANCET

VraSR Two-Component Regulatory System Contributes tomprF-Mediated Decreased Susceptibility to Daptomycin inIn Vivo-Selected Clinical Strains of Methicillin-Resistant Staphylococcus aureus

(2011) Shrenik Mehta et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Quantitative evaluation of cryptococcal pathogenesis and antifungal drugs using a silkworm infection model with Cryptococcus neoformans

(2011) Y. Matsumoto et al.   JOURNAL OF APPLIED MICROBIOLOGY

Drug discovery and development focusing on existing medicines: drug re-profiling strategy

(2011) T. Mizushima   JOURNAL OF BIOCHEMISTRY

Reduced Vancomycin Susceptibility in Staphylococcus aureus, Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications

(2010) B. P. Howden et al.   CLINICAL MICROBIOLOGY REVIEWS

Nosokomycins, new antibiotics discovered in an in vivo-mimic infection model using silkworm larvae. II: Structure elucidation

(2010) Ryuji Uchida et al.   JOURNAL OF ANTIBIOTICS

Nosokomycins, new antibiotics discovered in an in vivo-mimic infection model using silkworm larvae. I: Fermentation, isolation and biological properties

(2010) Ryuji Uchida et al.   JOURNAL OF ANTIBIOTICS